Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05799690Not ApplicableActive Not Recruiting

Comparison of Different Rehabilitation Protocols in Parkinson's Disease With Postural Instability and Gait Disorders

Role: lead

NCT04876352Not ApplicableCompleted

Virtual-reality for Upper Limb Rehabilitation in People With Parkinson's Disease

Role: lead

NCT06746896Active Not Recruiting

Retrospective Study on the Role of SCFA Modulation in Multiple Sclerosis

Role: lead

All 3 trials loaded